HealthRelyvrio ALS Drug Withdrawn by Manufacturer Due to Lack of Efficacy Due to FDA concerns about its efficacy, Relyvrio, an ALS medication, was removed from the market by Amylyx Pharmaceuticals.by Quincy Jon
HealthBrushstrokes In Paintings Can Predict Onset Of Neurodegenerative Diseases Like Alzheimer'sby Allan Adamson
Healthy Living/WellnessTwo-Fifths Of Parkinson's Patients Hide Symptoms, Diagnosis: Surveyby Angela Laguipo
Healthy Living/WellnessNew Implantable Capsule Releases Antibodies To Help Fight Alzheimer's Diseaseby Alyssa Navarro
Healthy Living/WellnessToxin From Algae Blooms May Cause Alzheimer's, Other Diseasesby Katrina Pascual
Healthy Living/WellnessStem Cell Therapy For Parkinson's Disease Gets Approval For Human Testingby Alyssa Navarro
Snapdragon 8 Elite Is Qualcomm's Answer to Apple's A18 Pro, Apple Intelligence, But Can It Rise Above?